Evidence map›Paper›PMID 41680725›Full record

ArticleBMC complementary medicine and therapies2026

Chemical composition and evaluation of the antibacterial and anti-migratory potentials of Anthemis maritima L. growing in North Africa.

Hamdoon A Mohammed, Fatma A Elshibani, Amr S Abouzied, Abdulnaser Kh Abdulkarim, Suliman A Almahmoud, Mohamed Bumadian, Najah Abraheem Altuhami, Mohamed A Sharkasi, Esra A El Naili, Ahmed Ismail

Abstract read
In one paragraph

Article in BMC complementary medicine and therapies, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Hamdoon A MohammedDepartment of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, Qassim University, Qassim, 51452, Saudi Arabia.ORCID http://orcid.org/0000-0003-2896-6790
Fatma A ElshibaniDepartment of Pharmacognosy, Faculty of Pharmacy, University of Benghazi, Benghazi, Libya.
Amr S AbouziedDepartment of Pharmaceutical Chemistry, College of Pharmacy, University of Hail, Hail, Saudi Arabia.
Abdulnaser Kh AbdulkarimDepartment of Basic Medical Science, Faculty of Pharmacy, University of Tripoli, Tripoli, Libya.
Suliman A AlmahmoudDepartment of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, Qassim University, Qassim, 51452, Saudi Arabia.
Mohamed BumadianDepartment of Botany, Faculty of science, University of Benghazi, Benghazi, Libya.
Najah Abraheem AltuhamiDepartment of Microbiology, Libyan Academy, Benghazi, Libya.
Mohamed A SharkasiDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Benghazi, Benghazi, Libya.
Esra A El NailiDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Benghazi, Benghazi, Libya.
Ahmed IsmailPharmacognosy Department, Faculty of Pharmacy, Fayoum University, Fayoum, 63514, Egypt. ais03@fayoum.edu.eg.ORCID http://orcid.org/0000-0003-0266-8760

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAnthemis maritima, endemic to Libya, holds promise for its medicinal properties, including anti-inflammatory, antioxidant, antibacterial, and wound-healing activities.

methodsThis work aims to explore the phytoconstituents present in methanolic extracts of Anthemis maritima aerial parts using LC-ESI-MS and assess their in vitro cytotoxic, anti-migratory, and antibacterial activities.

resultsPhytochemical analysis indicated the presence of 44 compounds, representing 11.77% of total peaks in the LC-chromatogram, including flavonoids, coumarins, sterols, and phenolic acids. Among the identified compounds, flavonoids represented 11.58%, of which 5,3’-dihydroxy-6,7,4’-trimethoxyflavone, cyanidin 3,5-diglucoside, astragalin, and kaempferol 3-O-rutinoside were the most abundant flavonoids in the plant extract. Cytotoxic assay showed marked activity of A. maritima extract, especially at a dose of 100 µg/mL, against A549 and Hep-2 cancer cell lines (IC50s = 49.49 and 67.93 µg/mL, respectively), while weaker activity was observed against HepG2 (IC50=107.95 µg/mL). Anti-migratory effects against A549, Hep-2, and HepG2 cancer cells were evaluated using a sub-cytotoxic dose of 50 µg/mL, with A549 and Hep-2 showing reduced rates of cell migration after 96 h of treatment (0.00535 and 0.00462 mm/hr, respectively), while HepG2 showed reduced rates in a 48-hour experiment (0.0062 mm/hr), which indicates that the extract decreases cancer metastasis. The plant extract exhibited antimicrobial efficacy against both Gram-positive and Gram-negative bacteria, showing significant activity against Pseudomonas aeruginosa (MIC, 1.6 µg/mL) in comparison to levofloxacin (MIC, 0.93 µg/mL). The selected compounds, identified via LC-ESI-MS, were subjected to docking studies to assess the binding scores and modes of these compounds compared to a reference standard. The study found that compounds such as cyanidin 3,5-diglucoside, kaempferol 3-O-rutinoside, and astragalin showed superior binding scores with the S. aureus gyrase-DNA complex compared to the reference ligand, indicating their potential as robust antibacterial agents.

conclusionsAnthemis maritima exhibits promising anti-migratory and antimicrobial properties. The promising microbial inhibition and in silico binding interactions of the plant constituents suggested that Anthemis maritima could be developed further for therapeutic use against resistant bacterial strains.

Indexed as

AnthemisAnti-Bacterial AgentsCell MovementPlant ExtractsAfrica, NorthernCell Line, TumorHep G2 CellsHumansMicrobial Sensitivity TestsAnti-Bacterial AgentsPlant ExtractsAnthemis maritimaAntibacterial activityAnti-migratoryCytotoxicLC-ESI-MS

Identifiers

PMID41680725
PMCPMC12931086

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.